CT
MRVI icon

Chicago Trust’s Maravai LifeSciences MRVI Stock Holding History

Chicago Trust’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,594
Closed -$296K – 307
2022
Q3 		$296K Hold
11,594
– – 0.08% 225
2022
Q2 		$330K Hold
11,594
– – 0.08% 215
2022
Q1 		$409K Hold
11,594
– – 0.09% 212
2021
Q4 		$486K Hold
11,594
– – 0.1% 205
2021
Q3 		$569K Hold
11,594
– – 0.13% 181
2021
Q2 		$483K Buy
+11,594
New +$449K 0.11% 184

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Chicago Trust's MRVI Position: Q4 2022 in Review

Chicago Trust sold out of Maravai LifeSciences (MRVI) in Q4 2022, closing a stake of 11,594 shares — an estimated $296K sold.

Chicago Trust first reported a position in MRVI in Q2 2021 and held it in 6 quarters. The position peaked at $569K in Q3 2021. 212 funds tracked by Wall St. Rank hold MRVI as of Q4 2022.

  • Chicago Trust reported no remaining Maravai LifeSciences position as of Q4 2022 after selling out during the quarter.
  • Chicago Trust sold 11,594 Maravai LifeSciences shares in Q4 2022, an estimated $296K.
  • Chicago Trust first reported a position in Maravai LifeSciences in Q2 2021 and held it in 6 quarters.
  • Chicago Trust's Maravai LifeSciences position peaked at $569K in Q3 2021.
  • 212 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2022.

Based on Chicago Trust's 13F filing for Q4 2022, filed 12 Jan 2023.